Literature DB >> 18591757

Comparison of patellar mobility in female adults with and without patellofemoral pain.

Susumu Ota1, Takeshi Nakashima, Ayako Morisaka, Kunio Ida, Morio Kawamura.   

Abstract

STUDY
DESIGN: Case control study.
OBJECTIVE: To compare the patellar mobility of female adult subjects with and without patellofemoral pain (PFP).
BACKGROUND: Although abnormal patellar mobility is believed to be one of the causes of PFP, there is currently no published evidence to support this contention. In part, this lack of evidence is because a reliable clinical measurement method to measure patellar mobility and objective criteria to define abnormal patellar mobility have not been established. METHODS AND MEASURES: The study sample was comprised of 22 females with PFP (PFP group) and 22 females who had no knee pain (control group), matched by age, height, and body mass index to the subjects with PFP. Patellar mobility was measured objectively using a specially designed apparatus. Measurements of lateral and medial patellar displacement, patellar mobility balance (lateral minus medial patellar displacement), lateral patellar mobility index (lateral patellar displacement divided by patellar width), and medial patellar mobility index (medial patellar displacement divided by patellar width) were used.
RESULTS: Lateral and medial patellar mobility values were not significantly different between the individuals in the PFP and control groups. When normal patellar mobility was arbitrarily defined as the average mobility +/- 2 SDs, based on the data from the control group, normal lateral patellar displacement was within a range of 7.2 to 17.6 mm and normal medial patellar displacement was within a range of 6.8 to 14.0 mm. The intraclass correlation coefficient for intratester and intertester reliability of lateral and medial patellar displacement measurements varied from 0.80 to 0.97.
CONCLUSION: Although there were no significant differences in patellar mobility between females with and without PFP, these measurements give reference information about normal patellar mobility for this group. LEVEL OF EVIDENCE: Diagnosis, level 5.

Entities:  

Mesh:

Year:  2008        PMID: 18591757     DOI: 10.2519/jospt.2008.2585

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  6 in total

1.  A new device for patellofemoral instrumented stress-testing provides good reliability and validity.

Authors:  Ana Leal; Renato Andrade; Betina B Hinckel; Marc Tompkins; Paulo Flores; Filipe Silva; João Espregueira-Mendes; Elizabeth Arendt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-06-28       Impact factor: 4.342

2.  CURRENT CONCEPTS AND TREATMENT OF PATELLOFEMORAL COMPRESSIVE ISSUES.

Authors:  Michael J Mullaney; Takumi Fukunaga
Journal:  Int J Sports Phys Ther       Date:  2016-12

3.  Relationship between patellar mobility and patellofemoral joint cartilage degeneration after anterior cruciate ligament reconstruction.

Authors:  Susumu Ota; Kazutoshi Kurokouchi; Shigeo Takahashi; Masaki Yoda; Ryuichiro Yamamoto; Tadahiro Sakai
Journal:  Nagoya J Med Sci       Date:  2017-11       Impact factor: 1.131

4.  Immediate effects of lumbopelvic manipulation and lateral gluteal kinesio taping on unilateral patellofemoral pain syndrome: a pilot study.

Authors:  Joseph Miller; Richard Westrick; Angela Diebal; Christopher Marks; J Parry Gerber
Journal:  Sports Health       Date:  2013-05       Impact factor: 3.843

5.  Patellar mobility can be reproducibly measured using ultrasound.

Authors:  Takashi Kanamoto; Yoshinari Tanaka; Yasukazu Yonetani; Keisuke Kita; Hiroshi Amano; Masashi Kusano; Mie Fukamatsu; Shinji Hirabayashi; Shuji Horibe
Journal:  J Orthop Traumatol       Date:  2014-06-04

6.  Patellar mobility and lower limb kinematics during functional activities in individuals with and without patellar tendinopathy.

Authors:  Rondy Michael Lazaro; Richard B Souza; Anthony C Luke
Journal:  Knee       Date:  2021-05-03       Impact factor: 2.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.